Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 EUR | -1.98% | -1.00% | -20.59% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
Sales 2024 * | 11.5M 12.3M | Sales 2025 * | 15M 16.04M | Capitalization | 138M 148M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 12 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.23 x |
P/E ratio 2024 * |
-9.9
x | P/E ratio 2025 * |
-22.8
x | Employees | 95 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 16.94% |
Latest transcript on Heidelberg Pharma AG
1 day | -1.98% | ||
1 week | -1.00% | ||
Current month | -4.81% | ||
1 month | -2.62% | ||
3 months | -8.33% | ||
6 months | +9.59% | ||
Current year | -20.59% |
Managers | Title | Age | Since |
---|---|---|---|
Andreas Pahl
CEO | Chief Executive Officer | - | 11-12-31 |
Walter Miller
DFI | Director of Finance/CFO | - | 23-04-30 |
András Strassz
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 05-04-28 | |
Georg F. Baur
BRD | Director/Board Member | 74 | 00-12-13 |
Birgit Kudlek
BRD | Director/Board Member | 57 | 12-05-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.97 | -1.98% | 4,704 |
24-04-25 | 3.03 | -0.33% | 4,000 |
24-04-24 | 3.04 | -1.30% | 4,000 |
24-04-23 | 3.08 | +2.67% | 2,687 |
24-04-22 | 3 | 0.00% | 1,279 |
Delayed Quote Xetra, April 26, 2024 at 11:36 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.59% | 151M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- HPHA Stock